ClearCure Bioscience’s pipeline is comprised of novel small molecules and new molecular entities invented to transform untreatable diseases to curable diseases and preventive paradigms. Our first to market product is the world’s first non-toxic IV immune, cell redox, and tissue therapy for hospitalized sepsis patients